Elysian Capital
Elysian Capital LLP is a London lower and mid-market private equity firm founded in 2007 by Ken Terry and Chai Patel, backing management buyouts of profitable UK and Ireland businesses with enterprise values of around GBP 20m to GBP 100m. It has raised three funds: Elysian Capital I (GBP 130m, 2010), Elysian Capital II (GBP 250m, 2015) and Elysian Capital III (GBP 325m, 2020). The firm is authorised and regulated by the UK Financial Conduct Authority under firm reference number 476691.
Key facts
Recent exits
Coverage notes
3 funds tracked, 24 portfolio companies (11 active · 13 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
24 companiesFunds & portfolio
Every fund Elysian Capital has raised, with its portfolio companies. Hand-checked from public filings.
Elysian Capital IIIBuyout2020 · 6yr€380M7 active · 1 realized
Unrealized
7 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Business Services |  UK | 2024 | |
| Industrials | UK | 2021 | |
| Industrials | UK | 2021 | |
| Business Services | UK | 2021 | |
| Business Services | UK | 2021 | |
| Healthcare | UK | 2025 | |
| Consumer | UK | 2021 |
UK· Entry 2024UK· Entry 2021UK· Entry 2021UK· Entry 2021UK· Entry 2021UK· Entry 2025UK· Entry 2021Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Business Services |  Ireland | 2022 | 2025 | – | – | – |
Ireland· Entry 2022Elysian Capital IIBuyout2015 · 11yr€293M4 active · 4 realized
Unrealized
4 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare | UK | 2019 | |
| Industrials | UK | 2020 | |
| Industrials | Ireland | 2019 | |
| Construction | UK | 2016 |
UK· Entry 2019UK· Entry 2020Ireland· Entry 2019UK· Entry 2016Realized
4 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Business Services | UK | 2018 | 2025 | Trade Sale | – | ||
| Consumer | UK | 2016 | 2024 | Trade Sale | – | ||
| Business Services | UK | 2017 | 2019 | IPO | – | ||
| Construction | UK | 2017 | 2023 | Trade Sale | – |
Elysian Capital IBuyout2008 · 18yr€152M0 active · 8 realized
Realized
8 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Energy | UK | 2013 | 2023 | Trade Sale | – | ||
| Healthcare | UK | 2013 | 2026 | MBO | |||
| Pharma | UK | 2010 | 2022 | MBO | – | ||
| Industrials | UK | 2014 | 2018 | Trade Sale | – | ||
| ClimateTech | UK | 2011 | 2018 | IPO | – | – | |
| Business Services | UK | 2008 | 2015 | Trade Sale | – | ||
| Mobility | UK | 2011 | 2015 | Trade Sale | – | ||
| HealthTech | UK | 2014 | 2020 | Trade Sale |
Saved GPs appear in your watchlist, one click from your workspace.
About Elysian Capital
Elysian Capital is a UK and Ireland lower-mid-market private equity firm with approximately £700 million of cumulative assets as of December 2024 (Fund III closed October 2020 at £325 million hard cap), headquartered in London. The firm was founded in 2007 by Ken Terry and Mark Puttick (Mark Puttick now CEO) and operates as a partner-owned LLP with unusually high personal capital commitments by partners. The 'More than a private equity firm. We're true partners' positioning reflects the partner-aligned model with significant personal capital commitments above industry norms.
Investment thesis
Elysian Capital deploys capital through three flagship funds (Elysian Capital I, II, III), targeting UK and Ireland lower-mid-market private equity acquiring majority stakes in growth businesses valued £20-100 million. The strategy emphasises partnership with entrepreneurial management teams plus operational value creation. Sector focus spans healthcare, business services, industrials, energy and utilities, business goods and marketing services. Geographic deployment is UK and Ireland core with US expansion support for portfolio companies.
Recent activity
Recent realised exits include industrials (Elysian II portfolio realisations, December 2025) and healthcare and industrials (United Living, 2023). Recent acquisitions include healthcare (IMS Euro, veterinary consumables, April 2025), business services (Activate Group, accident management, January 2024) and marketing services (Avant Group bolt-on for Gravity Global, July 2025; Gravity Global US bolt-ons, September 2025). The platform continues active deployment across the partner-aligned lower-mid-cap mandate. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
United Kingdom·€103.0B
United Kingdom·€86.6B
United Kingdom·€80.0B
United Kingdom·€70.8B
United Kingdom·€69.0B
United Kingdom·€43.1B
United Kingdom·€40.0B
United Kingdom·€18.0B
United Kingdom·€15.4B
United Kingdom·€15.0B
United Kingdom·€14.0B
United Kingdom·€13.8BGet the full picture on Elysian Capital.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in